7 years ago
Foresight Invests £1.25M in Fertility Focus Limited for OvuSense Growth
Foresight Group has invested £1.25m in Fertility Focus Limited, a fertility monitoring technology company, to support the growth of its OvuSense product
The investment will be used for sales and marketing and a clinical trial.
ProblemHealthcare
"Millions of women struggle to conceive due to irregular cycles or ovulatory conditions like Polycystic Ovarian Syndrome. Existing methods for predicting ovulation are often inaccurate or inconvenient, making it difficult for women to track their fertility and plan for pregnancy."
Solution
"OvuSense is a medical device that accurately predicts ovulation up to 24 hours in advance by monitoring core body temperature. It uses a proprietary algorithm and a smartphone app to provide real-time insights, empowering women to better understand their fertility and make informed decisions about family planning."
